Software facilitates contrast MDCT abdominal imaging.

Press Release Summary:

IQQA®-Liver Enterprise enables 4D imaging application, which supports physicians' real-time evaluation of liver and hepatic lesions, to run concurrently on hospital's existing PACS workstations. Combining image analysis algorithms and visualization tools, Enterprise software solution supports prompt and effective distilling of critical diagnostic information from data volumes of extraordinary size. Solution also performs automatic anatomic phase registration.

Original Press Release:

EDDA Technology to Introduce IQQA(R)-Liver Enterprise for Contrast MDCT

- Enabling Advanced 4D Clinical Application to Run Concurrently on Existing PACS Workstations

PRINCETON JUNCTION, N.J., June 4 -- EDDA Technology today announced that it is introducing IQQA(R)-Liver Enterprise for contrast Multi-Detector CT (MDCT) abdominal imaging at the upcoming Annual Meeting of the Society for Imaging Informatics in Medicine (SIIM). The enterprise software solution enables the advanced 4D imaging application, which supports physicians' real-time evaluation of liver and hepatic lesions, to run concurrently on hospital's existing PACS workstations.

IQQA(R)-Liver addresses the clinical challenge faced by physicians in efficiently dealing with tremendous data volume from contrast MDCT images of liver. Combining advanced image analysis algorithms and powerful visualization tools, the software supports physicians to quickly and effectively distill critical diagnostic information from data volume of extraordinary size. It performs automatic anatomic phase registration to allow simultaneous visualization and easy cross-referencing of lesion location and characteristics across the different phases. IQQA(R)-Liver further provides 3D segmentation and measurement tools for the visualization and analysis of liver lesions, hepatic vascular structures, as well as liver lobes. This volumetric analysis not only provides physicians with a powerful visualization aid, but also offers quantification tools to support their clinical decision making and patient care management.

IQQA(R)-Liver Enterprise is powered with the same enabling engine technology behind IQQA(R)-Chest Enterprise for digital radiography which the company introduced at RSNA 2006. The IQQA(R) Enterprise Engine (IQQA(R)-EE) aims to redefine how advanced clinical application can be accessed by radiologists and managed by radiology IT. Radiologists can now enjoy immediate access to the full real-time 3D/4D functionality of advanced clinical applications at existing PACS viewing stations. In addition, since the solution does not require code level integration with existing hospital PACS environment, application installation is completed quickly by simply setting up network communication. Possible additional maintenance resources of having to change with periodic PACS software upgrade are also saved.

"EDDA is committed to delivering new generation of diagnostic decision support solutions, which not only include advanced clinical applications to improve early detection, early diagnosis and precise treatment of lethal diseases, but also very importantly include innovations for ease of access of such applications," says Dr. Jian-Zhong Qian, President and CEO of EDDA Technology. "From the success of development of IQQA(R)-Chest Enterprise to IQQA(R)-Liver Enterprise, IQQA(R)-EE demonstrates a new economic way to integrate 2D/3D/4D applications with virtually any existing hospital PACS systems without code level integration. Advanced imaging applications in this way can readily run concurrently on hospital's existing PACS viewing stations with minimum installation and maintenance effort. Considering the trend of numerous advanced 3D/4D applications that already exist and many more that are emerging, the impact of such accessibility enabling technology will be significant."

Liver disease is among the 10 major causes of death in the US, according to the American Liver Foundation. There are 25,000,000 Americans afflicted by liver disease. Primary liver cancer, with approximately 1,000,000 cases reported every year in the world, is one of the most common malignancies. Liver metastasis tumors also occur frequently, as any primary cancer location can deposit metastases in the liver. As the liver is generally the first site of metastatic spread, aggressive surgical intervention at an early stage of metastasis results in a reported 25-40% five-year survival rate.

The IQQA(R)-Liver software has been in clinical use in several luminary Chinese hospitals for liver cancer detection, diagnosis and treatment planning purposes, including Eastern Hepatobiliary Surgery Hospital in Shanghai, Peking Union Medical College Hospital in Beijing, Shanghai Ruijin Hospital, and Beijing Youyi Hospital.

The IQQA(R) Enterprise Engine has been successfully integrated to run in numerous PACS environments including AGFA, GE, Kodak, McKesson, Philips and etc.

EDDA Technology will be exhibiting the IQQA(R) Family of Products in Booth #710 at the Annual Meeting of the Society for Imaging Informatics in Medicine (SIIM), Providence, RI, June 7 - June 9, 2007.

About EDDA Technology

EDDA Technology, Inc. is an innovative clinical computer solution provider in diagnostic imaging and analysis. EDDA offers a series of new generation software products to enable early detection of diseases, and enhance efficiency and precision in diagnosis and treatment. EDDA's goal is to with broad accessibility deliver advanced information analysis technologies that improve clinical workflow and accuracy. A privately held Delaware corporation, EDDA is headquartered in Princeton Junction, New Jersey, and has a subsidiary in Shanghai, China. In April 2006, EDDA entered into a strategic partnership with Philips Medical Systems to provide advanced digital radiography solutions to assist in the detection of lung lesions. IQQA is a registered trademark of EDDA Technology. For further information, please log on to http://edda-/, or call 609-936-8282.

CONTACT: Xiaolan Zeng, +1-609-936-8282 ext. 106,

All Topics